Cargando…

Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis

BACKGROUND: Interferon-α (IFN-α) is one of the central agents in immunotherapy for renal cell carcinoma (RCC) and binds to the IFN-α receptor (IFNAR). We investigated the role of IFNAR in RCC. METHODS: We quantified IFNAR mRNA expression in paired tumor and non-tumor samples from the surgical specim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamai, Takao, Yanai, Yoshiaki, Arai, Kyoko, Abe, Hideyuki, Yamanishi, Tomonori, Kurimoto, Masashi, Yoshida, Ken-Ichiro
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1988828/ https://www.ncbi.nlm.nih.gov/pubmed/17697365 http://dx.doi.org/10.1186/1471-2407-7-159

Ejemplares similares

Germline polymorphism of interferon-lambda3 is clinically associated with progression of renal cell carcinoma
por: Nukui, Akinori, et al.
Publicado: (2017)

Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma
por: Furuya, Nobutaka, et al.
Publicado: (2011)

Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma
por: Kamai, Takao, et al.
Publicado: (2009)

Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy
por: Nukui, Akinori, et al.
Publicado: (2017)

Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report
por: Kamai, Takao, et al.
Publicado: (2016)

Higher preoperative serum levels of PD‐L1 and B7‐H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF‐targeted therapy and unfavorable prognosis of renal cell carcinoma
por: Fukuda, Takehiko, et al.
Publicado: (2016)

Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival
por: Kamai, Takao, et al.
Publicado: (2021)

Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma
por: Kamai, Takao, et al.
Publicado: (2021)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosis
por: Yuki, Hideo, et al.
Publicado: (2018)

Clinical Significance of Serum Soluble T Cell Regulatory Molecules in Clear Cell Renal Cell Carcinoma
por: Masuda, Akinori, et al.
Publicado: (2014)

Protein Profiling of Blood Samples from Patients with Hereditary Leiomyomatosis and Renal Cell Cancer by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
por: Kamai, Takao, et al.
Publicado: (2012)

Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer
por: Yamaguchi, Yoshiyuki, et al.
Publicado: (2019)

Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer
por: Kamai, Takao, et al.
Publicado: (2010)

Circulating tumor cells and cell-free tumor DNA analyses in urothelial cancer using the LiquidBiopsy platform
por: Kobayashi, Minoru, et al.
Publicado: (2022)

Single minimum incision endoscopic radical nephrectomy for renal tumors with preoperative virtual navigation using 3D-CT volume-rendering
por: Kamai, Takao, et al.
Publicado: (2010)

Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma
por: Betsunoh, Hironori, et al.
Publicado: (2013)

Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma
por: Mizuno, Tomoya, et al.
Publicado: (2021)

Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer
por: Nukui, Akinori, et al.
Publicado: (2018)

Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density
por: Nukui, Akinori, et al.
Publicado: (2020)

Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case report
por: Yuki, Hideo, et al.
Publicado: (2014)

Elevated serum levels of cardiovascular biomarkers are associated with progression of renal cancer
por: Kamai, Takao, et al.
Publicado: (2018)

Clinically significant association between the maximum standardized uptake value on (18)F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer
por: Mizuno, Tomoya, et al.
Publicado: (2015)

Increased co-expression of stromal HHLA2 and fibroblast activation protein in upper tract urothelial carcinoma
por: Nishihara, Daisaku, et al.
Publicado: (2023)

Extravasation of Urine Associated with Bilateral Complete Ureteral Duplication, Vesicoureteral Reflux and Benign Prostatic Hyperplasia
por: Suzuki, Issei, et al.
Publicado: (2017)

Novel pegylated interferon‐β as strong suppressor of the malignant ascites in a peritoneal metastasis model of human cancer
por: Iwamura, Tomokatsu, et al.
Publicado: (2017)

Association of Nrf2 expression and mutation with Weiss and Helsinki scores in adrenocortical carcinoma
por: Kamai, Takao, et al.
Publicado: (2022)

A Case of Metastatic Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome-Associated Renal Cell Carcinoma Treated with a Sequence of Axitinib and Nivolumab Following Cytoreductive Nephrectomy
por: Yonese, Ichiro, et al.
Publicado: (2020)

Prognosis of metastatic renal cell carcinoma with first‐line interferon‐α therapy in the era of molecular‐targeted therapy
por: Kawano, Yoshiaki, et al.
Publicado: (2016)

The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells
por: Abe, Hideyuki, et al.
Publicado: (2014)

Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan
por: Eto, Masatoshi, et al.
Publicado: (2015)

Efficacy and safety of onabotulinumtoxinA in patients with overactive bladder: subgroup analyses by sex and by serum prostate-specific antigen levels in men from a randomized controlled trial
por: Yokoyama, Osamu, et al.
Publicado: (2021)

Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation
por: Kamai, Takao, et al.
Publicado: (2022)

Add-on Pegylated Interferon Alpha-2a Therapy in Chronic Hepatitis B Japanese Patients Treated with Entecavir
por: Tamai, Hideyuki, et al.
Publicado: (2017)

Hepatocyte Nuclear Factor 4 Alpha Is a Key Factor Related to Depression and Physiological Homeostasis in the Mouse Brain
por: Yamanishi, Kyosuke, et al.
Publicado: (2015)

Multidrug-Resistant Corynebacterium striatum Developed During Treatment of Ommaya Reservoir Infection
por: Kurimoto, Tomonori, et al.
Publicado: (2022)

Renal capsule metastasis from renal pelvic cancer: a case report
por: Kobayashi, Yasuyuki, et al.
Publicado: (2018)

Interferon-γ enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis
por: Kanai, Ryo, et al.
Publicado: (2021)

Type 1 interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma
por: Tomiyama, Yasuyuki, et al.
Publicado: (2011)

Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer
por: Hochmann, Sarah, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_23iacnc84lncsgb39kr971no6m